Glutathione S-transferase polymorphisms and susceptibility to neuroblastoma

Pharmacogenetics and Genomics

Volumn 15, Issue 6, 2005, Pages 423-426

  Lanciotti, Marina ^a   Coco, Simona ^a   Di Michele, Paola ^a   Haupt, Riccardo ^a   Boni, Luca ^b   Pigullo, Simona ^a   Dufour, Carlo ^a   Garaventa, Alberto ^a   Tonini, Gian Paolo ^b  

^a G GASLINI INSTITUTE   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

Genetic polymorphism; GSTs; Neuroblastoma

Indexed keywords

GLUTATHIONE; GLUTATHIONE TRANSFERASE; ISOLEUCINE; VALINE;

ADOLESCENT; AMINO ACID SUBSTITUTION; ARTICLE; CANCER SUSCEPTIBILITY; CAUCASIAN; CHILD; CLINICAL FEATURE; CODON; CONTROLLED STUDY; DRUG CONJUGATION; ENZYME ACTIVITY; GENE; GENE DELETION; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; GSTM1 GENE; GSTT1 GENE; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MULTIGENE FAMILY; NEUROBLASTOMA; PRIORITY JOURNAL;

EID: 20644440626     PISSN: 17446872     EISSN: None     Source Type: Journal    
DOI: 10.1097/01213011-200506000-00008     Document Type: Article

References (14)

1. Perera FP. Environment and cancer: who are susceptible? Science 1997; 278:1068-1073.
2. Salinas AE, Wong MG. Glutathione transferases: a review. Curr Med Chem 1999; 6:279-309.
3. Parkin DM, Kramarova E, Draper GJ, Masuyer E, Michaelis J, Neglia J, Qureshi S, Stiller CA (eds): International Incidence of Childhood Cancer. Lyon: International Agency for Research on Cancer; 1998.
4. Rebbeck TR. Molecular epidemiology of the human Glutathione S-transferase genotypes GSTM1 and GSTT1 in cancer susceptibility. Cancer Epidemiol Biomark Prevent 1997; 6:733-743.
5. Zimniak P, Nanduri B, Pikula S, Bandorowicz-Pikula J, Singhal SS, Srivastava SK, et al. Naturally occurring human Glutathione S-transferase GSTP1 isoforms with isoleucin and valin in position 105 differ in enzymatic properties. Eur J Biochem 1994; 224:893-899.
6. Chen CL, Liu Q, Pui CH, Rivera GK, Sandlund JT, Ribeiro R, et al. Higher frequency of Glutathione S-transferase deletions in black children with acute lymphoblastic leukemia. Blood 1997; 89:1701-1707.
7. Harries LW, Stubbins MJ, Forman D, Howard GC, Wolf CR. Identification of genetic polymorphisms at the glutathione S-transferase Pi locus and association with susceptibility to bladder, testicular and prostate cancer. Carcinogenesis 1997; 18:641-644.
8. Castleberry RP. Clinical and biologic features in the prognosis and treatment of neuroblastoma. Curr Opin Oncol 1992; 4:116-123.
9. Izbicki T, Mazur J, Izbicka E. Epidemiology and etiology of neuroblastoma: an overview. Anticancer Res 2003; 23:755-760.
10. Kaatsch P, Michaelis J. Epidemiological data on childhood malignancies in the first year of life. In: Lampert F, Cordera di Montezemolo I, Pession A (eds): Cancer in the First Year of Life. Basel: Karger; 1990, pp. 1-7.
11. Bunin GR, Ward E, Kramer S, Rhee CA, Meadows AT. Neuroblastoma and parental occupation. Am J Epidemiol 1990; 131:776-780.
12. Kristensen P, Andersen A, Irgens LM, Bye AS, Sundhem L. Cancer in offspring of parents engaged in agricultural activities in Norway: incidence and risk factors in the farm environment. Int J Cancer 1996; 65:39-50.
13. Daniels JL, Olshan AF, Teschke K, Hertz-Picciotlo I, Savitz DA, Blatt J, et al. Residential pesticide exposure and neuroblastoma. Epidemiology 2000; 12:20-27.
14. Thomas PT, Busse WW, Kerkvliet NI, Luster MI, Munson AE, Murray M, et al. Immunologic effects of pesticides. In: Baker SR, Wilkinson CF (eds): The Effects of Pesticides on Human Health: Advances in Modern Environmental Toxicology. Princeton, New Jersey: Princeton Scientific Publishing; 1990.